While elevated tumor TIMP-1 also predicted poor breast cancer specific survival in this study (Figure 2A), further stratification of the breast tumors into those with high and those with low NOS2 expression led to the observation that the association of TIMP-1 with poor survival seemed to be mainly restricted to tumors with high NOS2 expression (Figure 2B). Here, NOS2 is linked to breast carcinoma.